|
The landscape of POLE variants in colorectal and endometrial tumors: Correlation with microsatellite instability (MSI) and tumor mutation burden (TMB). |
|
|
Employment - WuXi Apptec (I) |
Patents, Royalties, Other Intellectual Property - Methods For Diagnosis And Treatment Of Patients Having Solid Tumors Published Application No.WO2018152154A1; Novel Diagnostic Method for Predisposition to Colorectal Cancer Patent No. US9157124B2; Summary; SYSTEMS AND METHODS FOR TREATING PATIENTS HAVING A GENETIC PREDISPOSITION TO DEVELOP PROSTATE CANCER Publication number: 20170073759 |
|
|
Employment - Caris Life Sciences |
Travel, Accommodations, Expenses - Caris Life Sciences |
|
|
Honoraria - Foundation Medicine |
Consulting or Advisory Role - Ability Pharma; Perthera; PierianDx |
Research Funding - Agios (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Loxo (Inst); Novartis (Inst); OncoMed (Inst); Rafael Pharmaceuticals (Inst) |
|
|
Honoraria - Boston Scientific; GlaxoSmithKline; Novocure |
Consulting or Advisory Role - Boston Scientific; Minnetronix Medical; NomoCan; Novocure; Novocure; Novocure; Novocure |
Research Funding - Novocure |
Travel, Accommodations, Expenses - GlaxoSmithKline |
|
|
|
Consulting or Advisory Role - Merck; Merck KGaA; Novartis; Taiho Pharmaceutical |
Research Funding - Bristol-Myers Squibb |
Travel, Accommodations, Expenses - Amgen; Merck; Merck KGaA |
|
|
No Relationships to Disclose |
|
|
Honoraria - Aptitude Health; Elsevier; IMEDEX |
Consulting or Advisory Role - Amgen (Inst); Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Genentech/Roche; Lilly (Inst) |
Research Funding - Array BioPharma (Inst); Bayer (Inst); Boston Biomedical (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Genentech/Roche (Inst); Lilly (Inst); Pfizer (Inst) |
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bayer; Boston Biomedical; Bristol-Myers Squibb; Genentech/Roche |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Aprea Therapeutics; Blueprint Medicines; Daiichi Sankyo; Global Blood Therapeutics; Guardant Health; Halozyme |
Speakers' Bureau - AstraZeneca |
|
|
Consulting or Advisory Role - Caris Life Sciences; ImaginAb; TransTarget |
Speakers' Bureau - Caris Life Sciences |
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Biomedical; Caris Life Sciences; Daiichi Sankyo; Eisai; Esperas Pharma; Esperas Pharma; Exelixis; Five Prime Therapeutics; H3 Biomedicine; Halozyme; ImaginAb; Incyte; Inovio Pharmaceuticals; Lexicon; LSK BioPharma; MSK Pharma; Nouscom; Plexxikon; Taiho Pharmaceutical; Torque; Xencor |
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget |
|
|
Employment - Caris Life Sciences; Indivumed |
Honoraria - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Merck; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical |
Speakers' Bureau - Amgen; Bayer/Onyx; Celgene; Genentech/Roche; Merck; Taiho Pharmaceutical |
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst) |
|
|
Research Funding - Ambry Genetics; AstraZeneca; Caris Life Sciences; Foundation Medicine; InVitae; Myriad Genetics |
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Caris Life Sciences; Foundation Medicine; Myriad Genetics |
Other Relationship - Caris Life Sciences; Foundation Medicine; Invitae; Myriad Genetics |